Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

298 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Active, not recruiting

Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

NCT06640517

Conditions
Plaque Psoriasis
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation Barnaul, Russia
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Dermatovenerological Dispensary" Chelyabinsk, Russia
  • Limited Liability Company "Health Azbuka Medical Center" Kazan', Russia
  • State Autonomous Healthcare Institution "Republic Clinical Dermatovenerologic Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor Ge" Kazan', Russia
View all 14 locations
View Trial Details
Active, not recruiting

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

NCT05172726

Conditions
Plaque Psoriasis
Locations
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Mission Dermatology Center Rancho Santa Margarita, California, United States
  • RM Medical Research Miami Lakes, Florida, United States
View all 19 locations
View Trial Details
Active, not recruiting

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

NCT06846541

Conditions
Moderate Psoriasis, Plaque Psoriasis, Psoriasis, +5 more
Locations
  • Total Dermatology Birmingham, Alabama, United States
  • Chandler Clinical Trials Chandler, Arizona, United States
  • Alliance Dermatology Pheonix, Arizona, United States
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
View all 268 locations
View Trial Details
Completed

An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis

NCT06488664

Conditions
Plaque Psoriasis
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation Barnaul, Russia
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Dermatovenerological Dispensary" Chelyabinsk, Chelyabinsk Oblast, Russia
  • Limited Liability Company "Ecology of Health" Chelyabinsk, Chelyabinsk Oblast, Russia
  • State budgetary institution of the Sverdlovsk region "Ural Research Institute of Dermatovenereology and Immunopathology" Yekaterinburg, Ekaterinburg, Russia
View all 34 locations
View Trial Details

Related conditions